Citigroup Inc Ionis Pharmaceuticals Inc Call Options Transaction History

Citigroup Inc

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 09, 2023	SELL	$38.5 - $47.13 $1.15 Million - $1.4 Million	-29,800 Reduced 52.01%	27,500 $1.25 Million
Q1 2023 May 11, 2023	BUY	$33.58 - $41.2 $1.92 Million - $2.36 Million	57,300 New	57,300 $2.05 Million
Q3 2022 Nov 10, 2022	BUY	$36.54 - $48.66 $1.1 Million - $1.46 Million	30,000 New	30,000 $1.33 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.